|
|
|
|
LEADER |
00806naa a2200265 i 4500 |
001 |
NSK01001022989 |
003 |
HR-ZaNSK |
005 |
20190307102617.0 |
007 |
ta |
008 |
190306s2017 ci a | |0|| ||eng |
035 |
|
|
|a (HR-ZaNSK)001022989
|
040 |
|
|
|a HR-ZaNSK
|b hrv
|c HR-ZaNSK
|e ppiak
|
041 |
0 |
|
|a eng
|b hrv
|
042 |
|
|
|a croatica
|
044 |
|
|
|a ci
|c hr
|
080 |
1 |
|
|a 616
|2 2011
|
100 |
1 |
|
|a Juretić, Antonio
|4 aut
|
245 |
1 |
0 |
|a Prostate cancer immunotherapy /
|c Antonio Juretić.
|
504 |
|
|
|a Bibliografija: 15 jed.
|
504 |
|
|
|a Sažetak
|
653 |
|
0 |
|a Imunoterapija
|a Liječenje
|a Karcinom prostate
|
773 |
0 |
|
|t Libri oncologici
|x 0300-8142
|g 45 (2017), 2/3 ; str. 69-71
|w nsk.(HR-ZaNSK)000011357
|
981 |
|
|
|b B03/17
|
998 |
|
|
|b gtao1903
|
856 |
4 |
1 |
|u https://hrcak.srce.hr/192193
|y Elektronička verzija članka
|